Retrophin Leadership

Zippia score 3.8

Job openings (10)

Retrophin executives

Here are further demographic highlights of the leadership team:

The Retrophin executive team is 56% female and 44% male.
64% of the management team is White.
10% of Retrophin management is Hispanic or Latino.
10% of the management team is Black or African American.

Work at Retrophin?

Share your experience

Rate Retrophin's leaders' effectiveness in guiding the company.

Name & TitleBio

Eric Dube Ph.d

Board Member

Eric Dube is based in Greater San Diego Area. He has worked as Head:North America at ViiV Healthcare; Senior VP/Head:Business Unit at GSK; and Board Member at RETROPHIN, INC.. Eric studied at DQ Entertainment between 2012 and 2012, Santa Clara University between 1991 and 1994, and Cornell between 1995 and 1999.

Casey Logan

Senior Vice President

Laura M. Clague

CFO

Elizabeth Reed

Senior Vice President, General Counsel

Laura M. Johnson

Senior Vice President

William E. Rote Ph.d

Senior Vice President of Research & Development

Chris Cline

Senior Vice President

Jula Inrig

Chief Medical Officer

Peter Heerma

Chief Commercial Officer

Gary Lyons

Board Member

Do you work at Retrophin?

Does leadership effectively guide Retrophin toward its goals?

Retrophin jobs

Retrophin board members

Name & TitleBio

Eric Dube Ph.d

Board Member

Gary Lyons

Board Member

Roy Baynes

Board Member

Stephen Aselage

Board Member

Suzanne Bruhn

Board Member

Retrophin highest paying jobs

Updated November 18, 2022

Zippia gives an in-depth look into the details of Retrophin, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Retrophin. The employee data is based on information from people who have self-reported their past or current employments at Retrophin. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Retrophin. The data presented on this page does not represent the view of Retrophin and its employees or that of Zippia.

Retrophin may also be known as or be related to RETROPHIN INC, Retrophin, Retrophin Inc, Retrophin, Inc. and Travere Therapeutics Inc.